about
A thermoresponsive and chemically defined hydrogel for long-term culture of human embryonic stem cells.Rapid establishment of the European Bank for induced Pluripotent Stem Cells (EBiSC) - the Hot Start experience.Human cloning: can it be made safe?Expression of FBN1 during adipogenesis: Relevance to the lipodystrophy phenotype in Marfan syndrome and related conditions5-azacytidine improves the osteogenic differentiation potential of aged human adipose-derived mesenchymal stem cells by DNA demethylationLineage-specific distribution of high levels of genomic 5-hydroxymethylcytosine in mammalian development.Novel Human Embryonic Stem Cell Regulators Identified by Conserved and Distinct CpG Island Methylation State.Neurotrophin signaling in oocyte survival and developmental competence: a paradigm for cellular toti-potency.Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage.The Molecular Karyotype of 25 Clinical-Grade Human Embryonic Stem Cell Lines.A scalable label-free approach to separate human pluripotent cells from differentiated derivatives.The road to providing human embryo stem cells for therapeutic use: the UK experience.Regulation of Na+,K(+)-ATPase alpha subunit gene expression during mouse preimplantation development.Human tonsil-derived follicular dendritic-like cells are refractory to human prion infection in vitro and traffic disease-associated prion protein to lysosomes.Red blood cells from pluripotent stem cells for use in transfusion.Dielectrophoresis: a review of applications for stem cell researchHot Start to European Pluripotent Stem Cell Banking.Derivation of the clinical grade human embryonic stem cell line RCe020-a (RC-16).Derivation of the clinical grade human embryonic stem cell line RCe016-A (RC-12).Derivation of the clinical grade human embryonic stem cell line RCe018-A (RC-14).Derivation of the clinical grade human embryonic stem cell line RCe017-A (RC-13).Derivation of the clinical grade human embryonic stem cell line RCe019-A (RC-15).Derivation of the human embryonic stem cell line RCe008-A (RC-4).Derivation of the human embryonic stem cell line RCe007-A (RC-3).Derivation of the human embryonic stem cell line RCe014-A (RC-10).Derivation of the human embryonic stem cell line RCe012-A (RC-8).Derivation of the human embryonic stem cell line RCe011-A (RC-7).Derivation of the human embryonic stem cell line RCe010-A (RC-6).Derivation of the human embryonic stem cell line RCM1.Derivation of the human embryonic stem cell line RCe006-A (RC-2).Derivation of the human embryonic stem cell line RCe009-A (RC-5).Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).Elasticity of human embryonic stem cells as determined by atomic force microscopy.Dielectrophoresis based discrimination of human embryonic stem cells from differentiating derivatives.Human parthenogenetic embryo stem cells: appreciating what you have when you have it.Variations in humanized and defined culture conditions supporting derivation of new human embryonic stem cell lines.Reprogramming of fibroblast nuclei after transfer into bovine oocytes.Effects of donor oocytes and culture conditions on development of cloned mice embryos.Effect of cell confluence on production of cloned mice using an inbred embryonic stem cell line.Germinal vesicle material is essential for nucleus remodeling after nuclear transfer.
P50
Q30533944-D8B2C526-1860-476A-9FFD-E9C9E5D7A023Q33459146-4AF166B1-AF8E-4963-8BF4-9D7D71A310C7Q34278634-C0AD5ED4-D15A-465E-99D4-E691C7C8948CQ34533265-3ECD18A2-BF87-42A1-9F3C-BC7B3811D341Q35113277-10561A9E-0C86-4C0E-8F70-F1D72848668EQ35348580-1F1AF009-174D-4B44-9487-DD27F66F0724Q35685337-DA878013-F89A-445A-ACDF-C9C46E11A9FCQ36020533-98CA1242-4E6B-465D-9CD5-411B4C9BC2D2Q36266493-59680CCF-323E-4337-9D8A-A1BB09025420Q36321047-DD155E31-3873-4227-AEBF-3AF1D5EE6DDCQ36468359-E34AE5B6-41FD-4A4E-9D10-1B10B42F37DDQ36637705-77490DD9-EE7C-411E-8E28-A88CDD57F328Q36744119-5A620D49-83F0-4888-BD17-288D9E0F34C9Q37415409-C5B0C5C4-644D-4F25-9AA7-08C1949C44F7Q37747344-D8698BBE-B557-4362-B261-2B3D6D1F8EA8Q37758254-D2B045A8-1B75-41DC-B1C1-1DE6BE391075Q38683021-FDD1CD17-73D7-439B-8435-6FA0807E6BF7Q38761770-9D0E76EF-B9F0-4EB0-A54B-3DE5194842EAQ38761774-2AEF652B-9566-46B2-A190-B23080A50821Q38761778-52F9BB37-2475-4503-8D7C-392C96FC646EQ38761782-11E1FBB2-6226-42F3-A493-604B4E3EBD37Q38761785-38491544-35F5-4400-9448-F2B3C882FB7AQ38761789-B161428E-29EF-4144-8515-A3206559FD56Q38761794-3B2E3BEE-47E7-4630-9672-1CC86947CE63Q38761822-493690DE-D129-44A4-8436-22A27BDEB3BDQ38761855-8D8379DA-7E03-42BD-AD1C-402F5D222ACDQ38761859-95B893BD-2848-44A4-B11D-E54649CAE472Q38761864-688D6CC6-1F47-4FEA-BA2B-E7ADDAACABA6Q38761868-3063FBFF-7C87-45D8-A572-42E53012333CQ38761886-86507DCB-7916-4D4F-BAFD-1FFF4EE59C9BQ38761921-BD5A8731-E3B6-4B5E-B630-78653323D37FQ38910429-A302904A-C07E-4B40-897F-AFA0D88337D8Q39445932-49D43976-00B6-497D-B779-30FE30A44949Q39669945-D349EAC1-4A33-4B35-B34F-C2121C3D88D2Q39997757-70971A63-FEB1-472E-BDB7-03840E0D2906Q40188775-29B91347-50A7-402B-BAFD-92EBE91C02CCQ40382120-556B8E86-06A7-4315-A37B-0A59D91CEB04Q40638820-360A48DD-B8F7-4951-8EC8-7530AAB6649FQ40676626-6DFA1C64-09E4-4B2B-818E-A3308B283935Q40709093-E5686C75-3A37-453D-86C0-50AE80567890
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Paul De Sousa
@ast
Paul De Sousa
@en
Paul De Sousa
@es
Paul De Sousa
@nl
Paul De Sousa
@sl
type
label
Paul De Sousa
@ast
Paul De Sousa
@en
Paul De Sousa
@es
Paul De Sousa
@nl
Paul De Sousa
@sl
prefLabel
Paul De Sousa
@ast
Paul De Sousa
@en
Paul De Sousa
@es
Paul De Sousa
@nl
Paul De Sousa
@sl
P1053
H-7416-2013
P106
P21
P31
P3829
P496
0000-0003-0745-2504